Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) Fair Value & Analysis
Healthcare · US · Market cap $223K
Fair value as of: Aug 13, 2026
From 1 valuation models · updated 4 days ago
Fair value updated Aug 13, 2026, revised from $0.0010 to $0.0009 (−10.3%) since Jul 31, 2026. Share price −10.0% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (4 months)
White line = price, green steps = our fair value per fiscal year. As of Aug 13, 2026.
How to read this chart
4‑month range $0.0009 – $0.0010 · the $0.0009 price screens below the $0.0009 fair value. As of Aug 13, 2026.
Analysis
Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) currently trades at $0.0009, while our model-based Fair Value estimate is $0.0009, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC generated revenue of $2.0M at a net margin of -91.1%. Revenue declined 56.7% year over year. Fundamentals as of Aug 13, 2026
The share trades about 10% below its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at 0%, VENCF screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when VENCF reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 37 · Market factors (momentum, volatility) 46
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is a venture capital firm specializing in seed/startups and early venture. It prefers to invest in cannabis sectors. The firm prefers to invest in companies based in United States, North America and beyond. Vencanna Ventures Inc. is based in Calgary, Canada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC reported revenue of $4.0M in FY2025 versus $0 in FY2022. Reported net income was −$3.9M in FY2025.
Watch VENCF: get an alert when its fair value changes →
Peer Group
Drug Manufacturers - Specialty & Generic · 625 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥53.76 | ¥25.94 | -52% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,944 | ₹989.50 | -49% |
| Divi's Laboratories Limited DIVISLAB | ₹8,500 | ₹1,932 | -77% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,915 | ₹1,163 | -76% |
| PharmaEssentia Corporation 6446 | 1,440 TWD | 233.93 TWD | -84% |
| Cipla Limited CIPLA | ₹1,463 | ₹1,001 | -32% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,167 | ₹703.32 | -40% |
| Lupin Limited LUPIN | ₹2,281 | ₹2,477 | +9% |
| Mankind Pharma Limited MANKIND | ₹2,433 | ₹983.11 | -60% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,200 | ₹874.79 | -27% |
Compare Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) overvalued or undervalued?
What is the fair value of VENCF?
What is the quality score of VENCF?
What is the revenue of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
What is the net profit margin of VENCF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.